Through pseudo-time analysis, we identified genes such as NCBP2, EIF3D, and NUDT4 boost the occurrence and development of malignant tumor epithelial cells, providing guidance for identifying potential therapeutic targets for CRC. This evidence concerns the gene NUDT4 and colorectal carcinoma.